Influence of proteinuria on glycated albumin values in diabetic patients with chronic kidney disease

Internal Medicine

Volumn 50, Issue 1, 2011, Pages 23-29

  Okada, Tomonari ^a   Nakao, Toshiyuki ^a   Matsumoto, Hiroshi ^a   Nagaoka, Yume ^a   Tomaru, Ryo ^a   Iwasawa, Hideaki ^a   Wada, Toshikazu ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Chronic kidney disease; Diabetes mellitus; Glycated albumin; Glycated hemoglobin; Glycemic control; Proteinuria

Indexed keywords

BIOLOGICAL MARKER; CREATININE; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CHRONIC GLOMERULONEPHRITIS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROSCLEROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN URINE LEVEL; PROTEINURIA;

ADULT; AGED; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC; SERUM ALBUMIN;

EID: 78651262704     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4129     Document Type: Article

References (24)

1. Rossinig K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH. Progression of nephropathy in type 2 diabetic patients. Kidney Int 66: 1596-1605, 2004.
2. Wu MS, Yu CC, Yang CW, et al. Poor pre-dialysis glycemic control is a predictor of mortality in type 2 diabetic patients on maintenance haemodialysis. Nephrol Dial Transplant 12: 2105-2110, 1997.
3. Morioka T, Tahara H, Emoto M, et al. Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care 24: 909-913, 2001.
4. Nakao T, Matsumoto H, Okada T, et al. Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis. Inter Med 37: 826-830, 1998.
5. Okada T, Nakao T, Yamanaka T, Tamekuni T, Ikeda K. Influence of darbepoetin-a therapy on HbA1c values in hemodialysis patients. Clin Nephrol 72: 244-246, 2009.
6. Chujo K, Shima K, Tada H, Oohashi T, Minakuchi J, Kawashima S. Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA). J Med Invest 53: 223-228, 2006.
7. Inaba M, Okuno S, Kumeda Y, et al. Glycated albumin is a better indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol 18: 896-903, 2007.
8. Peacock TP, Shihabi ZK, Bleyer AJ, et al. Comparison of glycated albumin and hemoglobin A1c levels in diabetic subjects on hemodialysis. Kidney Int 73: 1062-1068, 2008.
9. Miyashita Y, Nishimura R, Morimoto A, Matsudaira T, Sano H, Tajima N. Glycated albumin is low in obese, type 2 diabetic patients. Diabetes Res Clin Pract 78: 51-55, 2007.
10. Koga M, Otsuki M, Matsumoto S, Saito H, Mukai M, Kasayama S. Negative association and its related chronic inflammation with serum glycated albumin but not glycated hemoglobin levels. Clin Chim Acta 378: 48-52, 2007.
11. Koga M, Kasayama S, Kanehara H, Bando Y. CLD (chronic liver disease)-HbA1c as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases. Diabetes Res Clin Pract 81: 258-262, 2008.
12. Koga M, Murai J, Saito H, Matsumoto S, Kasayama S. Effects of thyroid hormone on serum glycated albumin levels: study on nondiabetic subjects. Diabetes Res Clin Pract 84: 163-167, 2009.
13. Okada T, Nakao T, Matsumoto H, Yamanaka T, Nagaoka Y, Tamekuni T. Influence of age and nutritional status on glycated albumin values in hemodialysis patients. Inter Med 48: 1495-1499, 2009.
14. Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982-992, 2009.
15. Kaysen GA. Albumin turnover in renal disease. Miner Electrolyte Metab 24: 55-63, 1998.
16. Tahara Y, Shima K. Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 18: 440-447, 1995.
17. Freedman BI, Shihabi ZK, Andries L, et al. Relationship between assays of glycemia in diabetic subjects with advanced chronic kidney disease. Am J Nephrol 31: 375-379, 2010.
18. Brown JN, Kemp DW, Brice KR. Class effect of erythropoietin therapy on hemoglobin A1c in a patient with diabetes mellitus and chronic kidney disease not undergoing hemodialysis. Pharmacotherapy 29: 468-472, 2009.
19. Ng JM, Jennings PE, Laboi P, Jayagopal V. Erythropoetin treatment significantly alters measured glycated haemoglobin (HbA1c). Diabet Med 25: 239-242, 2008.
20. Fukuoka K, Nakao K, Morimoto H, et al. Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis. Nephrology 13: 278-283, 2008.
21. Okada T, Nakao T, Matsumoto H, et al. Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal failure. Inter Med 46: 807-814, 2007.
22. Kumeda Y, Inaba M, Shoji S, et al. Significant correlation of glycated albumin, but not glycated hemoglobin, with arterial stiffening in haemodialysis patients with type 2 diabetes. Clin Endocrinol 69: 556-561, 2008.
23. Yamada S, Inaba M, Shidara K, et al. Association of glycated albumin, but not glycated hemoglobin, with peripheral vascular calcification in hemodialysis patients with type 2 diabetes. Life Sci 83: 516-519, 2008.
24. Takahashi S, Uchino H, Smimizu T, et al. Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: Usefulness of GA for evaluation of short-term changes in glycemic control. Endocr J 54: 139-144, 2007